Source: Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Umme Kolsum, Thomas Southworth, Natalie Jackson, Dave Singh. Blood eosinophil counts in COPD patients compared to controls. Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019

Member's Comments

No comment yet.

Related content which might interest you: Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Reproducibility of COPD blood eosinophil counts Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 The reproducibility of COPD blood eosinophil counts Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018 Year: 2018 Peripheral blood eosinophil counts and serum total IgE on broncholdilator responsiveness in patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003 The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018 Year: 2018 Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Blood eosinophil in smokers and mild and moderate COPD patients Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Stability of sputum and blood eosinophil levels in COPD Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Blood eosinophil as a biomarker in COPD Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Clinical significance of blood neutrophil differential count in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Association between blood eosinophil counts and risk of rehospitalization in patients with asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Blood EOSinophil counts in asthmatic patients in Italy (EOS study) Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Blood eosinophils and exacerbation rate in COPD patients over three years Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018